Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

Circulation

Volumn 102, Issue 2, 2000, Pages 179-184

  Lemieux, Isabelle ^a   Pascot, Agnès ^a   Couillard, Charles ^a   Lamarche, Benoît ^a   Tchernof, André ^a   Alméras, Natalie ^a   Bergeron, Jean ^a   Gaudet, Daniel ^a   Tremblay, Gérald ^a   Prud'homme, Denis ^a   Nadeau, André ^a   Després, Jean Pierre ^a  

^a Pavilion Mallet ^*

Author keywords

Apolipoproteins; Coronary disease; Insulin; Lipids; Lipoproteins; Waist circumference

Indexed keywords

APOLIPOPROTEIN B; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ABDOMEN; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY RISK; HUMAN; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034636818     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.2.179     Document Type: Article

References (28)

1. Sniderman AD, Shapiro S, Marpole D, et al. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human low density (β) lipoproteins]. Proc Natl Acad Sci USA. 1980;77:604-608.
2. Lamarche B, Moorjani S, Lupien P-J, et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec Cardiovascular Study. Circulation. 1996;94:273-278.
3. Yamell JWG, Sweetnam PM, Marks V, et al. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly Prospective Study. Br Heart J. 1994;71:293-296.
4. Després J-P, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996; 334:952-957.
5. Campos H, Genest JJ, Blijlevens E, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
6. Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study. Circulation. 1997;95:69-75.
7. Lamarche B, Tchernof A, Mauriège P, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 1998;279:1955-1961.
8. Pouliot MC, Després JP, Nadeau A, et al. Visceral obesity in men: associations with glucose tolerance, plasma insulin and lipoprotein levels. Diabetes. 1992;41:826-834.
9. Pouliot M-C, Després J-P, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460-468.
10. Tchernof A, Lamarche B, Prud'Homme D, et al. The dense LDL phenotype: associations with plasma lipoprotein levels, visceral obesity and hyperinsulinemia in men. Diabetes Care. 1996;19:629-637.
11. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28:2077-2080.
12. Allain CC, Poon LS, Chan CSG, et al. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
13. Havel RJ, Eder H, Bragdon HF. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
14. Burstein M, Samaille J. Sur un dosage rapide du cholestérol lié aux β-lipoprotéines du sérum. Clin Chim Acta. 1960;5:609.
15. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Ann Biochem. 1966;15:45-52.
16. Moorjani S, Dupont A, Labrie F, et al. Increase in plasma high density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism. 1987;36:244-250.
17. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab. 1971;37:732-738.
18. Standardization of anthropometric measurements. In: Lohman T, Roche A, Martorel R, eds. The Airlie (VA) Consensus Conference. Champaign, Ill: Human Kinetics; 1988:39-80.
19. Ferland M, Despres JP, Tremblay A, et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr. 1989; 61:139-148.
20. Gaudet D, Vohl MC, Julien P, et al. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angio-graphically assessed coronary artery disease among French Canadians. Am J Cardiol. 1998;82:299-305.
21. Gaudet D, Vohl MC, Perron P, et al. Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Circulation. 1998;97:871-877.
22. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta. 1987;166:1-8.
23. 2+ precipitation procedures for quantitation of high-density lipoprotein cholesterol. Clin Chem. 1982;28:1379-1387.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
25. McNamara JR, Jenner JL, Li Z, et al. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb. 1992;12:1284-1290.
26. Manninen V, Tenkanen L, Koshinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation. 1992;85:37-45.
27. Després JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev. 1993;6:137-159.
28. Wald NJ, Law M, Watt HC, et al. Apolipoproteins and ischemic heart disease: implications for screening. Lancet. 1994;343:75-79.